Table 1. Demographic, Clinicopathologic, and Treatment Characteristics of Patients With Pancreatic Cancer Who Underwent Pancreatic Resection.
Characteristic | Data (n = 2786)a |
---|---|
Age, mean (SD), y | 67.0 (10.7) |
Sex | |
Male | 1394 (50.0) |
Female | 1392 (50.0) |
Race | |
White | 2308 (82.8) |
Black | 152 (5.5) |
Asian/Pacific Islander | 313 (11.2) |
Other/unknown | 13 (0.5) |
Elixhauser comorbidity index score, mean (SD)b | 13.9 (8.9) |
Tumor grade | |
Well differentiated | 295 (10.6) |
Moderately differentiated | 1373 (49.3) |
Poorly differentiated or undifferentiated | 949 (34.1) |
Unknown | 169 (6.1) |
T category | |
T1 | 204 (7.3) |
T2 | 435 (15.6) |
T3 | 2147 (77.1) |
N category | |
N0 | 1054 (37.8) |
N1 | 1725 (61.9) |
NX | 7 (0.3) |
Stage | |
I | 399 (14.3) |
II | 2387 (85.7) |
Chemotherapy | |
None | 1070 (38.4) |
Preoperative | 89 (3.2) |
Postoperative | 1238 (44.4) |
Preoperative and postoperative | 50 (1.8) |
Unknown | 339 (12.2) |
Radiotherapy | 874 (31.4) |
Pancreatic resection | |
Pancreaticoduodenectomy | 2207 (79.2) |
Distal pancreatectomy | 387 (13.9) |
Total pancreatectomy | 98 (3.5) |
Other | 94 (3.4) |
Complication within 30 d | 1037 (37.2) |
Readmission within 30 d | 565 (20.3) |
Length of stay, median (IQR), d | 12 (9-18) |
Surgery hospitalization costs, mean (SD), $c | 60 939 (56 779) |
Follow-up, median (IQR), mo | 20 (10-35) |
Vital status | |
Death due to pancreatic cancer | 2020 (72.5) |
Death due to other cause | 247 (8.9) |
Death due to unknown cause | 55 (2.0) |
Alive | 464 (16.7) |
High-volume hospital | 1297 (46.6) |
NCI-designated cancer center | 1127 (40.5) |
Teaching hospital | 1428 (51.3) |
Abbreviations: IQR, interquartile range; NCI, National Cancer Institute.
Unless otherwise indicated, data are expressed as number (percentage) of patients. Percentages have been rounded and may not total 100.
Scores range from −11 to 62, with higher scores indicating a greater number of comorbidities.
Includes the index surgical hospitalization and readmissions within 30 days.